Clinical trial NCT01688232 - References

Colorectal Cancer — The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Citation(s)

•   Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F
  Type, density, and location of immune cells within human colorec
•   Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman WH, Pagès F, Galon J
  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin O
•   Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J
  In situ cytotoxic and memory T cells predict outcome in patients with early-stage color

Colorectal Cancer: a Prospective Multicentric Study of the in Situ Immune Infiltrate for the Identification of the Patients at High Risk of Relapse

Details for clinical trial NCT01688232